Relibeta Injection
Prescription Required
Product introduction
Relibeta Injection is a prescription medicine used in the treatment of multiple sclerosis (a disease in which the immune system cells starts damaging the insulating covers of the brain and spinal cord cells leading to different types of physical, mental and psychiatric problems).
Relibeta Injection is used to treat serious long-term infections (chronic hepatitis B and hepatitis C) of liver.
Relibeta Injection is used to treat serious long-term infections (chronic hepatitis B and hepatitis C) of liver.
Uses of Relibeta Injection
Benefits of Relibeta Injection
In Multiple sclerosis (MS)
Multiple sclerosis (MS) is a disease of the brain and spinal cord in which a person’s own immune system attacks the protective sheath (called myelin) of the nerves. This leads to symptoms such as vision loss, pain, fatigue and improper coordination. Relibeta Injection helps to suppress the body’s immune system, thereby reducing the progression of the disease. It reduces the inflammation of the damaged nerves, prevents further damage and stabilises your immune system. This medicine is given as an injection by a doctor or nurse and should not be self-administered. Follow your doctor’s instructions carefully to get the best results.
Side effects of Relibeta Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Relibeta
- Headache
- Sweating
- Fever
- Chills
- Flu-like symptoms
How to use Relibeta Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Relibeta Injection.
Pregnancy
CONSULT YOUR DOCTOR
Relibeta Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Relibeta Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
UNSAFE
Relibeta Injection may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
CAUTION
Relibeta Injection should be used with caution in patients with severe kidney disease. Dose adjustment of Relibeta Injection may be needed. Please consult your doctor.
Liver
CAUTION
Relibeta Injection should be used with caution in patients with liver disease. Dose adjustment of Relibeta Injection may be needed. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Relibeta Injection
₹6785.0/Injection
AVONEX 30 MCG INJECTION
Biogenetic Pharmaceuticals
₹9557/injection
41% costlier
Quick tips
- Relibeta Injection is given as an injection into the muscles, usually 3 times a week.
- Do not skip any dose and finish the complete course even if you feel better.
- Use caution while driving or doing anything that requires concentration as Relibeta Injection can cause dizziness.
- Your doctor may regularly monitor your liver function, thyroid function, and blood cell counts while taking this medicine.
- Talk to your doctor if you notice sudden mood changes or develop suicidal thoughts.
Fact Box
Chemical Class
Amino Acids, Peptides, and Analogues
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
Interferons
Patient concerns
User feedback
Patients taking Relibeta Injection
Once A Week
100%
What are you using Relibeta Injection for?
Multiple scle*
94%
Others
6%
*Multiple sclerosis (MS)
How much was the improvement?
Average
44%
Excellent
30%
Poor
26%
What were the side-effects while using Relibeta Injection?
Flu-like symp*
40%
Headache
20%
Sweating
20%
Itching
20%
*Flu-like symptoms
How do you take Relibeta Injection?
With or witho*
100%
*With or without food
Please rate Relibeta Injection on price
Expensive
67%
Not Expensive
33%
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Interferon beta-1a. Maidenhead, Berkshire: Biogen Idec Ltd.; 1997 [revised Aug. 2018]. [Accessed 25 Jan. 2019] (online) Available from:
- Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Interferon Beta. [Updated 2020 Jan 20]. [Accessed 20 Feb. 2020] (online) Available from:
- Interferon Beta-1A. 1996 [revised Feb. 2012]. [Accessed 25 Mar. 2019] (online) Available from:
Marketer details
Name: Reliance Life Sciences
Address: Dhirubhai Ambani Life Sciences Centre, R-282, TTC Area of MIDC, Thane-Belapur Road, Rabale, Navi Mumbai 400 701
Country of origin: India
Lab tests offered by us
Related/Popular tests
1,889 people viewed this recentlyMRP
₹6785
Inclusive of all taxes
0.5 ml in 1 prefilled syringe
SOLD OUT
Notify me